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resumo 
 
 
As células estaminais são uma classe distinta de células, devido às suas 
capacidades de regeneração e diferenciação em vários tipos de células 
especializadas. Os nichos onde estas se encontram servem-lhes de 
sustentação e permitem a sua manutenção num estado indiferenciado, 
afectando a sua regeneração e diferenciação através de estímulos. As células 
estaminais dividem-se em duas classes: embrionárias (pluripotentes) e adultas 
(multipotentes), embora também existam células estaminais pluripotentes 
induzidas. 
Nos últimos anos tem-se estudado a possibilidade de utilizar sistemas 
baseados em células estaminais no estudo de neuropatologias. Assim sendo, 
os objectivos desta dissertação foram o isolamento e proliferação de células 
estaminais da mucosa olfactiva, a indução destas células para a formação de 
neurosferas e a sua diferenciação para células tipo neuronais (NLC) e células 
derivadas de neurosferas (ONS). Também se procedeu à diferenciação das 
ONS e à caracterização dos modelos celulares NLC e ONS. Para se atingir os 
objectivos definidos, foram recolhidas biópsias de mucosa olfactiva e isolaram-
se células estaminais de epitélio e da lâmina própria. As células estaminais da 
mucosa olfactiva proliferaram e foram induzidas a formar neurosferas com um 
meio de cultura específico (DMEM/F12 com ITS-X, EGF e FGF2). As 
neurosferas foram posteriormente diferenciadas em células ONS (com meio 
DMEM/F12) e em NLC (com meio neurobasal suplementado com NGF, B27, 
glutamina e glutamato). Imagens obtidas durante o tempo de diferenciação das 
NLC foram analisadas tendo em conta parâmetros morfométricos. As células 
ONS foram adaptadas à cultura em meio sem soro e diferenciadas em células 
tipo neurónios (usando meio DMEM/F12 com N2 e meio DMEM/F12 com B27). 
Os resultados obtidos indicam que estabelecemos culturas primárias de 
células estaminais da mucosa olfactiva de rato. A eficiência dos protocolos de 
isolamento e proliferação foi confirmada pela marcação com nestina através de 
imunofluorescência e pela formação de neurosferas. A análise morfométrica 
das NLC indicou que diferenciámos as neurosferas para células tipo neuronal, 
devido à sua morfologia neuronal e à expressão do marcador neuronal β-
tubulina III. Foram também estabelecidas culturas de células ONS, 
posteriormente diferenciadas através da redução de soro, apresentando um 
fenótipo tipo neuronal quando mantidas em meio definido. Contudo, devem ser 
realizadas experiências futuras para a caracterização deste novo modelo 
celular. Os nossos resultados permitem-nos concluir que estabelecemos e 
caracterizámos novos sistemas modelo baseados em células estaminais. 
Estes resultados são relevantes uma vez que tais modelos podem ser usados 
para o estudo de mecanismos celulares e moleculares envolvidos em 
inúmeras neuropatologias, nomeadamente na Doença de Alzheimer. 
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abstract 
 
Stem cells are a distinct class of cells, characterized by their ability to self-
renew and differentiate into several specialized cell types. The niche of stem 
cells provides them support, favors their existence in an undifferentiated state 
and affects, by stimuli, their self-renewal and cellular fate. Stem cells can be 
divided in two broad classes: embryonic (pluripotent) and somatic stem cells 
(multipotent), although induced pluripotent stem cells are also a reality 
nowadays. 
The possibility of investigating neuropathologies using stem cell based systems 
has attracted interest among researchers in the last few years. Therefore, the 
main objectives of this dissertation were the isolation and proliferation of 
olfactory mucosa stem cells that were further induced to form neurospheres 
and further differentiated into neuron-like cells (NLC) and olfactory 
neurosphere-derived cells (ONS). ONS differentiation and the characterization 
of NLC and ONS model systems were also performed. For the accomplishment 
of these objectives, olfactory mucosa biopsies were collected and epithelium 
and lamina propria stem cells isolated. The well proliferating olfactory mucosa 
stem cells were induced to form neurospheres using a specific culture medium 
(DMEM/F12 supplemented with ITS-X, EGF and FGF2). The neurospheres 
were then differentiated into ONS cells (using DMEM/F12 medium) and into 
NLC (using neurobasal medium supplemented with NGF, B27, glutamine and 
glutamate). Morphometric analysis of neuron-like cells was performed on 
microphotographs taken at several time points during the differentiation 
procedure. ONS cells were adapted to serum deprivation and differentiated into 
neuronal-like cells (using DMEM/F12 with N2 medium and DMEM/F12 with B27 
medium). 
Our results indicate that we successfully established primary rat cultures from 
olfactory mucosa stem cells. The efficiency of the isolation/proliferation 
procedure was confirmed by positive immunostaining with stemness marker 
nestin and also by their ability to form neurospheres. The morphometric 
analysis of NLC revealed that we successfully differentiated neurosphere-
forming cells into neuron-like cells, since they assume a neuronal like 
phenotype and they highly express the neuronal marker β-tubulin III. 
Additionally, ONS cultures were established and further differentiated by 
gradual serum deprivation. In fact, these cells presented neuronal-like 
phenotypic characteristics when cultured in defined medium. However, 
additional experiments for characterization of this new model system should be 
performed. From our results we can conclude that we efficiently established 
and characterized new stem cells model systems. These results are of 
paramount importance since they will be used for the study of cellular and 
molecular mechanisms underlying several neuropathologies, including 
Alzheimer’s disease. 
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1.1. Stem cells 
The human body is composed by over two hundred different cell types that are organized 
into tissues and organs, providing all the functions required for its viability and reproduction (1). 
The cellular developmental potency (range of commitment options available to a cell) is 
progressively narrowed as development proceeds from a fertilized egg to the adult. Zygotes and 
early blastomers are thought to be the pinnacle of the cellular hierarchy of developmental 
potency, due to their totipotency (ability to orchestrate the formation of an entire organism, 
including extra-embryonic tissues such as placenta). However, unlike stem cells, fertilized eggs are 
not able to self-renew by simple cell division (2, 3). 
Stem cells are a distinct class of cells, since they preserve, to varying extents, the potential 
for multi-lineage differentiation (2, 4). Thereafter, these cells are defined by their self-renewal 
and differentiation ability, as they are able to unlimitedly produce daughter cells equivalents to 
themselves but with more restricted properties (Figure 1) (5, 6).  
 
Figure 1 - Differentiation of stem cells. Stem cells behavior is influenced by its niche, formed by the stem cell (S) and 
niche cells, and extracellular matrix (ECM) proteins, secreted factors and physical factors, such as stiffness and stretch 
(blue and red thick arrows). This environment allows stem cells to divide asymmetrically to produce (A) a stem cell that 
remains in the niche and (B) a progenitor cell, that depending on the combination of extrinsic factors to which they are 
exposed can differentiate along different pathways (1 and 2) to generate distinct terminally differentiated cells (TDC). 
ROS – reactive oxygen species. P – progenitor cell, P1 – progenitor cell 1, P2 – progenitor cell 2. Adapted from (7). 
 
Mammalian stem cells can divide in a symmetric or asymmetric manner in order to 
regulate their number and tissue homeostasis. The symmetric division enlarges the stem cells 
pool while asymmetric cell division generates one daughter cell that remains at the niche and one 
more rapidly-dividing cell that exits and differentiates and is named progenitor cell (Figure 1) (8-
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11). Also known as transient amplifying cells, these committed mature progenitors with limited 
proliferative capacity and restricted differentiation potential are responsible for increasing the 
number of differentiated cells produced by each stem cell division (Figure 1) (7, 10).  
The niche of stem cells is the cellular microenvironment that provides them support, 
favors their existence in an undifferentiated state and affects, by stimuli, self-renewal and cellular 
fate (4). Aspects such as adhesion to extracellular matrix (ECM) proteins, direct contact with 
neighboring cells, exposure to secreted factors and physical factors like oxygen tension and sheer 
stress are known to influence stem cells behavior (Figure 1) (1). 
Stem cells can be divided in two broad classes according to their origin, that are different 
in the degree of developmental potency: embryonic and somatic stem cells, although induced 
pluripotent stem cells are also a reality nowadays (Figure 2) (12). 
 
 
 
Figure 2 - Types and origin of stem cells. Cells are described as totipotent if they can form an entire organism, including 
extraembryonic tissues. If they can form all cell types of the adult organism they are named pluripotent. Embryonic 
stem cells can be derived from inner cell mass (ICM) of blastocysts, post-implantation epiblast and primordial germ 
cells. In adults, there can be found multipotent and unipotent cells (only one differentiated lineage), that can be 
reprogrammed to plutipotency by several reprogramming strategies. epiSCs – epiblast stem cells, EGCs – embryonic 
germ cells, ESCs – embryonic stem cells, CNS - central nervous system, iPS – induced pluripotent stem cells. Adapted 
from (1). 
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1.1.1. Embryonic stem cells 
Embryonic stem cells (ES cells) are the most potent, pluripotent stem-cell lines derived 
from the inner cell mass of pre-implantation mammalian embryos or the early blastocyst, before 
formation of the tissue germ layers (4). Moreover, ES cells can also be derived from primordial 
germ cells (EGCs) that arise in the late embryonic and early fetal stage of development (13). These 
cells have two distinct properties: unlimited self-renewal capacity and pluripotent developmental 
potency similar to their embryonic founder cells, being able to differentiate into cells and tissues 
of all three germ layers (ectoderm, mesoderm and endoderm) in vivo and in vitro (2, 5). 
ES cells were firstly isolated in 1981 from mouse blastocyst (14) and were first derived 
from human blastocysts in 1998 (15). Ten years later, in January 2009, the US Food and Drug 
Administration approved the first clinical trial involving human ES cells, to evaluate the safety of 
ES cell-derived oligodendrocytes in repair of spinal cord injuries (1). Nowadays, several human ES 
cell lines exist and banking of clinical grade cells is ongoing. 
These cells are particularly interesting for researchers since they allow the analysis of the 
relationships between gene function and cell and tissue development, as well as explore early 
human development through in vitro differentiation, which recapitulates aspects of normal 
gastrulation and tissue formation (15, 16). 
In spite of the actual ethical issues and challenges on defining specific cell types and 
routes of transplantation and engraftment, ES cells represent a very attractive model since they 
could also be a source of cells for cell-based therapy with optimal immunological matching of 
donor and recipients (1, 2). 
  
1.1.2. Somatic stem cells 
Somatic stem cells, also known as postnatal or adult stem cells (although they can be 
extracted from newborns and adolescents), are undifferentiated cells found among differentiated 
cells within a tissue or organ. They can actively replenish themselves through self-renewal and 
regenerate the multiple lineages that comprise an entire tissue or tissues, therefore these cells 
are considered multipotent. The pools of somatic stem cells are responsible for the regeneration 
of highly proliferative tissues (that turn over rapidly throughout adulthood, replacing their mass in 
a matter of days), such as blood, skin and gut epithelia (2, 4). Nevertheless, stem cells are also 
present in tissues that normally undergo very limited regeneration, such as the brain and liver. 
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Adult stem cells are maintained in a quiescent state (G0 state, out of cell cycle and in low 
metabolic state), though they are able to exit quiescence and rapidly expand and differentiate in 
response to an external stimuli like the stress (17). However, for many adult stem cell types, there 
are problems with accessibility, low frequency (<1/2% of the total cellularity), restricted 
differentiation potential and poor in vitro growth (5, 18). 
Recent work has questioned the lineage restricted characteristics of adult stem cells, by 
the observation that some multipotent cells can transdifferentiate when relocated, originating 
other specialized cells appropriate to their new niche (18-20). Transdifferentiation means that 
somatic multipotent stem cells of tissues such as the hematopoietic system, the intestine or the 
skin are inherently plastic and capable of generating cell types outside of their primary lineage 
(e.g. hematopoietic stem cells contributing to non-hematopoietic tissues). However, 
transdifferentiation concept is currently a controversial issue, only rarely observed (3, 21).  
According to their own features, somatic stem cells can be divided into several groups, 
from which hematopoietic, mesenchymal, epithelial and neural stem cells are the best well 
studied and characterized. 
 
1.1.2.1. Neural stem cells 
Neogenesis of mature cells persists throughout adult life within discrete brain regions of 
the central nervous systems (CNS) of all mammals (22). In humans, it occurs predominantly in the 
subgranular zone (SGZ) of the dentate gyrus in the hippocampus and in the subventricular zone 
(SVZ) of the forebrain lateral ventricles (23). This process is crucial for the maintenance of brain 
integrity, plasticity and optimal function, due to its central role in the generation and integration, 
both functional and synaptic, of new neurons into pre-existing neural networks. 
During the differentiation process in SVZ, multipotent type B astrocytes (stem cell), that 
were identified as the bona fide SVZ stem cells, give rise to fast-cycling transiently proliferating 
precursor cells that are called type C precursors (transiently amplifying cell). These precursors 
generate mitotically active type-A neuroblasts that, while dividing, migrate tangentially towards 
the olfactory bulb, where they move to the outer cell layers (Figure 3). Once there, they integrate 
as new interneurons - periglomerular and granule neurons (22, 23). 
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Figure 3 - Generation of new interneurons in the subventricular zone (SVZ). Sagittal section through the lateral 
ventricle, showing the larger area of adult neurogenesis. The type B astrocytes (red) give rise to type C precursors 
(green) and, sequentially, to type A neuroblasts (yellow) that migrates through the rostral migratory stream (RMS) till 
the olfactory bulb (OB). Adapted from (23). 
 
In the SGZ is seen a slightly similar cellular hierarchy, with the type B astrocyte as the true 
stem cell. These astrocytes produce the intermediate type D precursors that eventually give rise 
to the type G granule neurons, that will integrate functionally into the granule cell layer (22, 23) 
(Figure 4). 
 
Figure 4 - Generation of new granule neurons in the subgranular zone (SGZ). Schematic representation of the dentate 
gyrus and the subgranular zone. Type B astrocytes (red) give rise to type D precursors (green) and then to type G 
granule neurons (blue), that will integrate into the granule cell layer. Adapted from (23). 
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Adult neural stem cells were firstly isolated from the adult CNS from rodents (24) and 
later on from humans (25). In the forebrain, neural stem cells were identified based on their 
ultrastructural characteristics observed by electron microscopy. However, this approach does not 
allow the purification of live stem cells, and definitive markers for their purification by flow 
cytometry have yet to be identified (8). 
Multipotent neural progenitors are readily and extensively expandable when placed in 
culture and stimulated with the appropriate growth factors, such as epidermal growth factor 
(EGF) and fibroblast growth factor 2 (FGF2) (26, 27). This valuable feature allows adult neural 
stem cells to be isolated and investigated regarding their functional characteristics and 
developmental potential. Analysis of intrinsic and extrinsic mechanisms that control the various 
steps of neurogenesis, including proliferation, survival, fate specification, neuronal migration, 
maturation and synapse formation, may also be performed (22). 
The demonstration of active adult neurogenesis opens possibilities to adult CNS repair 
after injury or degenerative neurological diseases using cell replacement therapy. 
 
1.1.2.2. Other types of somatic stem cells 
Much of the knowledge on stem cells arose from information obtained with 
hematopoietic stem cells (HSCs). HSCs are present mainly in bone marrow, but also in umbilical 
cord, peripheral blood and fetal liver, being responsible for the generation of all the mature blood 
cells in the body (red blood cells, platelets, lymphoid and myeloid cells) (18). In spite of the rarity 
of these cells (1/10000 to 1/100000 of total blood cells), since 1988 first umbilical cord blood 
transplantation, umbilical cord and peripheral blood have been used as allogeneic stem cell 
source (28). 
In bone marrow, however, we can also found mesenchymal stem cells (MSCs) (18). These 
non-hematopoietic stromal cells are capable of differentiating into, and contribute to the 
regeneration of, mesenchymal tissues such as bone, cartilage, muscle, ligament, tendon and 
adipose (29). MSCs and MSC-like cells have now been isolated from a wide range of sources other 
than the bone marrow, including adipose tissue, amniotic fluid, periosteum and fetal tissues, and 
show phenotypic heterogeneity (30). MSCs are potentially suitable for use in allogeneic and 
autologous transplantation due to their high proliferative potential, which have drawn 
researchers’ attention into the prospective use of these cells for reparative/regenerative 
treatment of diseases affecting mesodermal tissues and even in neurological treatments (31). 
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As continuous sheets of tightly linked cells that constitute the surfaces and linings of the 
body, epithelia provide a protective envelope against the external environment and regulate 
water and nutrients absorption and glandular secretions (32). Epithelial stem cells are therefore 
essential to sustain tissue turnover and repairment of epithelia after injuries. Different 
populations of epithelial stem cells can generate tissues that display several cellular architectures 
and functions as distinct as epidermis and intestine. 
 
1.1.3. Induced pluripotent stem cells 
In the last decade, engineering of pluripotency into somatic cells by the ectopic 
expression of transcription factors linked to pluripotency emerged. The resulting induced 
pluripotent stem cells (iPS cells) were firstly described in 2006 (33) and are the functional 
equivalents of ES cells in terms of morphology, growth properties, multi-lineage differentiation in 
vitro, teratoma formation and germline transmission. They also express ES cell marker genes (33) 
and even have the ability to create an entire embryo (from iPS cells injected into tetraploid 
blastocysts, that alone cannot support somatic development) (2, 34). 
Several strategies have been employed to induce this conversion of lineage-restricted 
cells into a pluripotent state – nuclear transplantation, cellular fusion or explantation, culture-
induced reprogramming and infection with virus (3, 35). 
Some groups were capable of reprogram mouse embryonic and human somatic cells to 
produce iPS cells by the introduction of a set of transcription factors linked to pluripotency – the 
transcription factors Oct3/4, Sox2, Klf4 and Myc, under ES cell culture conditions (33, 34, 36). 
There are also reports describing the generation of iPS cells from fibroblasts and mesenchymal 
cells of patients with a variety of genetic diseases with either Mendelian or complex inheritance 
such as Down syndrome, Huntington and Alzheimer’s disease (16, 37). 
The development of a method for establishing such immortal cultures not only from 
healthy individuals but also from disease conditions would offer an unprecedented opportunity to 
recapitulate both normal and pathologic human tissue formation in vitro, thus enabling disease 
investigation, drug and autologous cell therapies development (16, 38). The iPS can be easily 
differentiated into neurons (39), although their wide application as models of brain diseases faces 
significant technical challenges along with the cost and time required to establish and maintain 
each cell line, which may reduce the ability to compare cells from multiple patients (40). 
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Since iPS cells represent a patient’s own genetic make-up, any tissue derived from the line 
would necessarily be histocompatible, allowing rejection-proof cell transplantation and 
eliminating contentious ethical and technical considerations. However, since hES cells were first 
described in 1998 (15), and human iPS cells only in middle 2006 (33), there can be anticipated 
some 10–15 years before effective products are developed, thereby launching the era of 
regenerative medicine (2). 
 
 
1.2. Mammalian olfactory system 
Animals discriminate and recognize numerous chemical signals in their environment with 
high sensitivity and specificity, which strongly bias their behavior and provide them vital 
information for survival. The mammalian olfactory system regulates a wide range of multiple and 
integrative functions such as physiological regulation, emotional responses (e.g. fear, pleasure), 
reproductive functions (e.g. sexual and maternal behaviors) and social behaviors (e.g. recognition 
of similar, family and strangers). To achieve such a variety of functions, two anatomically and 
functionally separate sensory organs, that are sit at the interface of the environment and the 
central nervous system, are required – the vomeronasal organ (VNO) and the olfactory epithelium 
(OE) (41). 
The vomeronasal organ is specialized in sensing non-volatile chemical compounds (e.g. 
pheromones), especially concerning the origin of the source. VNO unbranched axons project 
through an opening in the cribriform plate of the skull to the accessory olfactory bulb (AOB), 
which in turn transmits sensory information to the vomeronasal amygdala (VA) and then to 
specific nuclei of the hypothalamus (Figure 5). This accessory organ provides information about 
the social and sexual status of other individuals within the species (42). 
Since humans (and other species) have not retained a fully functional vomeronasal system 
during adaptation to terrestrial life (41),  the olfactory epithelium completes its functions. OE is 
responsible for the detection of airborne volatile molecules called odorant compounds (or 
odorants). This neuroepithelium is connected to the next central station of olfactory information 
processing, the main olfactory bulb (MOB), and then, by mitral cells, to distinct brain nuclei such 
as the anterior olfactory nucleus (AON) and the olfactory tubercule (OT) (Figure 5).  
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Figure 5 - Schematic view of the two mammalian olfactory systems. In the main olfactory system (red arrows), the 
olfactory information is transmitted from the main olfactory epithelium (MOE) to the main olfactory bulb (MOB) and 
then to distinct brain nuclei - anterior olfactory nuclei (AON), piriform cortex (PC), olfactory tubercle (OT), lateral part of 
the cortical amygdala (LA) and entorhinal cortex (EC). In the vomeronasal system (brown arrows), the information 
detected in the vomeronasal organ (VNO) is transmitted to the accessory olfactory bulb (AOB), then to the vomeronasal 
amygdala and finally to the hypothalamus (H). Adapted from (41). 
 
1.2.1. Olfactory mucosa 
The human olfactory mucosa (Figure 6) comprises a pseudostratified columnar epithelium 
resting on a highly cellular lamina propria and occupies 2 cm2 of the superior portion of the nasal 
vault, overlying the superior nasal septum, the cribriform plate and the superior part of the 
superior turbinate (43). 
Being the only surface neural cells of the body, but deeply related to the central nervous 
system, the olfactory mucosa has attracted a renewed interest among researchers as an early 
marker provider on neurodegenerative conditions, such as schizophrenia, Alzheimer’s and 
Parkinson’s disease (44-46). Several neurodegenerative diseases are also partially associated to 
disorders of smell, not only in the identification and discrimination of odors but also in the odor 
threshold (47). Besides, olfactory neurosphere-derived cells (ONS) have many advantages over ES 
and iPS cells, namely the non-requirement of genetic reprogramming and the presence of 
disease-dependent alterations in gene expression and cell functions (45, 46). Patient-derived 
olfactory mucosa stem cells shown a shorter cell cycle (48) and faster proliferation (49) in 
schizophrenia , oxidative stress in Parkinson’s disease (50) and altered cell migration in familial 
dysautonomia (51). There are ongoing studies over the potential of olfactory mucosa as source for 
autologous stem cell therapy, namely for Parkinson’s disease, with encouraging results (52). 
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Cells from olfactory mucosa can be obtained via septum biopsy through the external naris 
under endoscopic visualization, local anesthesia and vasoconstriction, a procedure that must be 
carried out by an Ear Nose and Throat (ENT) surgeon (53, 54). In spite of carrying some inherent 
theoretical risks, including leak of cerebrospinal fluid, there are no report in literature of severe 
complications or any adverse effect in the sense of smell after biopsy of the olfactory regions (54). 
 
 
Figure 6 - Schematic representation of histological arrangement of cells in the olfactory mucosa. The olfactory 
epithelium (OE), adjacent to the nasal cavity, is composed by sustentacular cells (yellow), that surround  olfactory 
receptor neurons (green). The epithelial stem cells, globose (red and blue) and horizontal basal cells (pink), lye on the 
basal lamina (BL). On the opposite side of the BL there are olfactory ecto-mesenchymal stem cells (purple). The axons of 
the olfactory neurons that protrude from epithelium into lamina propria (LP) are supported by the olfactory 
ensheathing cells (orange). Adapted from (11). 
 
1.2.1.1. Olfactory epithelium 
Structurally, the olfactory epithelium (OE) resembles the germinative neuroepithelia of 
the embryo that gives rise to CNS and it is composed by four cell types. From the apical surface to 
the basal lamina, they are sustentacular cells (SUS), ciliated bipolar olfactory receptors neurons 
(ORNs), microvillar cells and basal cells (44). 
Sustentacular or supporting cells, that are analogous to glial cells of the brain, surround 
olfactory receptor neurons, probably contributing to the regulation and maintenance of an 
appropriate ionic environment around the receptor neurons for olfactory transduction to occur 
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(11). They function as metabolic and physical supports for ORNs (55) and are also responsible for 
the phagocytosis of dead neurons (56). The ciliated bipolar olfactory receptor cells form the bulk 
of the OE and project a single dendrite to the surface of the olfactory neuroepithelium and a 
single axon to the olfactory bulb. The dendrites of these 10 to 20 million bipolar neurons have a 
thickened end known as olfactory vesicle or knob, that contains non-motile cilia with G-protein-
coupled seven-transmembrane domains receptors, where odor molecules bind. The axons cross 
the basement membrane of the epithelium into the lamina propria, join together into fascicles 
and nerves, and pass through the cribriform plate to synapse within the olfactory bulb with mitral 
cells and interneurons, some of which generated by neurogenesis in the SVZ (57). 
Microvillar cells are supposed to be a second morphological distinct class of 
chemoreceptors, however their role in the olfaction has not yet been fully defined (44). 
The basement membrane is composed by basal cells that are a population of multipotent 
stem cells, divided in two distinct types, capable of continuously regenerating olfactory receptor 
neurons throughout life (44). 
 
1.2.1.2. Olfactory lamina propria 
Separated from the epithelium by a basal lamina and lining in the nasal cartilage, the 
lamina propria (LP) contains axon fascicles, blood vessels, connective tissue and Bowman’s glands, 
whose secretions are probably essential for the olfactory transduction (44, 58). 
The axons of the olfactory neurons that protrude from epithelium into lamina propria are 
supported by an extra line of specialized glial cells: the olfactory ensheathing cells (OECs). These 
cells guide the regeneration, elongation and migration of non-myelinated olfactory axons, by 
producing neurotrophic and neurite promoting factors, and ECM proteins. Therefore, several 
reports described the potential of OECs on the improvement of functional recovery (by 
remyelination of axons) and axonal re-growth after lesions of the CNS (spinal cord injury) and 
peripheral nervous system (nerves lesion) (59-61). In addition, a population of multipotent stem 
cells can also be found in the LP (53, 62). 
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1.2.2. Neurogenesis in the olfactory system 
The cells of the olfactory mucosa are in direct contact with the environment and are 
greatly vulnerable to damage by toxins, infectious agents or trauma, what makes constant 
neurogenesis an essential feature for this tissue to maintain critical sensory function. 
Therefore, in the adult olfactory system there are at least two germinative zones, where 
life-long turnover of neurons persists regulated by the same inductive signals (such as 
neurotrophic factors, retinoic acid and forskolin) (63, 64). One zone is located in the sensory 
organ, where cell renewal and differentiation are responsible for the replacement of olfactory 
sensory neurons (65), while the second area resides near the ventricle of the forebrain (41).  
The first site of neurogenesis is made possible by the presence of olfactory 
neuroepithelium stem cells found deep in the olfactory epithelium, near the basal lamina that 
separates the epithelium from the underlying lamina propria. Globose and horizontal basal cells 
lie near the basal lamina of the epithelium and have the ability to produce not only neurons but 
also cells outside the neural lineage (66), such as their ensheatment and supporting cells (67-70). 
Besides, lamina propria might also provide a source for stem cells in cases of extensive epithelial 
damage, by the olfactory ecto-mesenchymal stem cells (71). 
 
 
1.3. Olfactory mucosa-derived stem cells 
1.3.1. Epithelium-derived stem cells: HBCs and GBCs 
Since the first description of regenerative activity of mice epithelium after axotomy in 
1940 (72), there has been a long-running debate over the identity of the true olfactory stem cell 
population. However, and despite a lack of firmly established stem role, two types of epithelium-
derived stem cells are now accepted to contribute to the neurogenic process. Resting in the basal 
germinal zone and committed to different fates, there can be found globose basal cells (GBCs) 
and horizontal basal cells (HBCs) (57, 62, 73). 
The GBCs represents the major proliferating population, rapidly dividing transit 
amplifying, that contain round multipotent progenitors with scant cytoplasm (64). They can give 
rise to olfactory sensory neurons (OSNs), sustentacular cells and, rarely, duct/gland cells and 
ciliated respiratory epithelial cells (69). On the other hand, HBCs are present as a heterogeneous 
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population in a single-cell layer below the GBCs, in direct contact with the basal lamina, and are 
suggested to be more broadly potent, able to generate both neuronal and glial cell types (73).  
The justification to this greater degree of pluripotency may be the particular ECM environment in 
which they are included, at the interface between neuronal and glial environments. The majority 
of adult HBCs are quiescent neural crest-derived cells (55) and, like other non-neural systems, this 
population divide rarely, probably due to a tight regulation meant to preserve genomic integrity 
(68). 
There is no morphological distinction between HBCs and GBCs. However, direct lineage 
examination showed that HBCs can replenish GBCs progenitors and indirectly repopulate both 
neuronal and non-neuronal differentiated lineages of the epithelium after extensive injury (56, 
73, 74). HBCs are then presently regarded as ‘true tissue stem cells’ of the olfactory epithelium, 
although their cell-lineage and differentiation controlling mechanisms remain unknown (57). 
 
1.3.2. Lamina propria-derived stem cells: OE-MSCs 
Since their discovery in 2009 (71), lamina propria-derived olfactory stem cells have been 
the focus of several studies (53, 62). It is known that exists a strong relationship between these 
cells and the OE, but their biological function is still unknown. There are, however, some 
evidences that molecular signaling between LP and OE influences the olfactory pathway 
formation (75) and that during adulthood, particularly after induced lesion, there can be observed 
cells migrating from one compartment to another (62, 76). 
Lamina propria-derived stem cells were described to be easily expanded and 
differentiated into neural and non-neural cell types in vitro and in vivo (66). When compared to 
bone marrow mesenchymal stem cells (BM-MSCs), these olfactory stem cells display a higher 
proliferation rate, higher clonogenicity, a susceptibility to differentiate into osseous cells and a 
low inclination to give rise to chondrocytes and adipocytes, although they can produce fat 
droplets and calcium deposits (76, 77). Being originated from a neural crest-derived tissue, 
exhibiting an increased expression of genes involved in neurogenesis and a resident of  connective 
tissue, they are further named olfactory ecto-mesenchymal stem cells (OE-MSC) (62). 
Therefore, olfactory mucosa represents a nonepithelial source of multipotent cells that 
might contribute to the autologous transplant-mediated repair of the CNS injury after nasal 
mucosa biopsy and transplantation (78, 79). There was the description of hippocampal neuronal 
networks reestablishment after OE-MSCs injection into cerebrospinal fluid or transplantation of 
Establishing model systems from olfactory mucosa stem cells 
 
16 
 
hippocampal injured mice. OE-MSCs migrated to the affected areas and stimulated endogenous 
neurogenesis, restored synaptic transmission and enhanced long-term potentiation (80). Besides, 
other report describe the transplantation of adult human OE-MSCs into the cochlea of a mouse 
model of early-onset sensorineural hearing loss as a contributor to the reduction of the hearing 
loss (81). Recently, purified OE-MSCs were described to highly induce oligodendrocytes 
myelination in vitro, with a more robust and efficient effect than BM-MSCs in an eventual 
transplant scenario (with glial cells) for spinal cord injury (76). 
 
1.3.2.1. Isolation and proliferation of OE-MSCs 
In every living individual, olfactory mucosa is easily accessible and it can be safely 
collected even in humans, by an ENT specialist, without any consequences in olfaction (53, 54).  
The procedure of isolating olfactory stem cells that follows olfactory mucosa biopsy is 
meticulously described (Figure 7) in a previous report (53). Briefly, after biopsy, the explants 
collected can be used for molecular studies aiming to identify biomarkers in brain diseases. 
Otherwise, in rodents, the lamina propria could be enzymatically (Dispase II enzyme) separated 
from the contiguous neuro-epithelium and then stem cells can be obtained by dissociation of the 
purified LP using enzymatic (Collagenase IA enzyme) and non-enzymatic procedures (mechanical 
actions). However, if the tissue is human, after the isolation of LP from the underlying OE, it must 
be sliced into some pieces and inserted under glass coverslips  (53). Purified olfactory stem cells 
can, at this point of the procedure, be used for comparative omics (genomic, transcriptomic, 
epigenomic, proteomic) studies, aiming to identify molecular markers of CNS diseases (45). 
Moreover, these stem cells can then be either grown in large numbers, using a serum-
containing appropriate culture medium, as an adherent monolayer, and banked in liquid nitrogen 
or induced to form three-dimensional spheres on lysine substrate. Presumably, these lamina-
propria derived neurospheres, grown in a serum-free medium supplemented with mitogens, 
represent a population of neural cells in different stages of maturation formed by single, clonally 
expanding precursors that form tightly packed cellular structures, heterogenous in morphology 
(spherical, ovoid, and irregular) with a well-defined, phase-bright perimeter (67, 71, 82) (Figure 8). 
To induce the formation of an higher number of neurospheres, epidermal growth factor (EGF) and 
basic fibroblast growth factor (FGF2) were used (53), due to their combined mitogenic role in 
neural stem cells culture (26). The olfactory neurospheres detach from the culture dish and 
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become free-floating spheres when their diameter reach about 100 µm (45). These neurospheres 
in suspension must be collected and dissociated enzymatically or mechanically to be re-plated. 
 
  
Figure 7 - Overall schematic representation of the olfactory ecto-mesenchymal stem cells (OE-MSCs) isolation. OM – 
olfactory mucosa; LP – lamina propria. Adapted from (53). 
 
Since the first report on the proliferation and generation of multipotent clones of cells 
(neurospheres) isolated from adult striatum cells in 1992 (24), those culture conditions - the 
neurosphere assay - have been used to isolate and characterize other types of candidate stem cell 
from various other tissues, including skin (83), heart (84) and breast (85). 
This neurosphere assay represents a serum-free, selective culture system in which most 
differentiating or differentiated cells rapidly dye, whereas stem cells and non-stem precursor cells 
respond to mitogens, divide and form neurospheres that can be dissociated and re-plated to 
generate secondary spheres or differentiated mature cells, demonstrating self-renewal over an 
extended period of time (more than five passages) (23, 86, 87). There are descriptions of 
neurospheres differentiation into neurons and glia, but also cells of non-ectodermal lineage, 
including developing cardiac and skeletal muscle, kidney, liver and blood (66). 
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When lamina-propria sphere derived cells are re-plated in a serum-containing medium 
they give rise to olfactory neurosphere-derived cells (ONS), that grow in an adherent monolayer 
with a flat, undifferentiated appearance and with a marker phenotype similar to the 
ectomesenchymal cells derived from primary cultures of OM - GFAP (~50%), β-tubulin III (~10-
15%) and O4 (~2-5%) (45, 53, 62). ONS cells represent very practical models for brain diseases 
because they are not genetically modified and can be quickly generated in large numbers to 
produce homogeneous populations for functional assays, providing repeatable cell populations 
for high throughput screening for drug discovery (39). 
 
 
Figure 8 - Culture and differentiation of olfactory ecto-mesenchymal stem cells (OE-MSCs). OE-MSCs proliferate (A) in 
a serum-containing culture medium. When plated in lysine-coated culture dishes with serum-free medium and growth 
factors, neurospheres start to appear (B). Free-floating neurospheres can be collected, dissociated and re-plate with the 
appropriate medium to form olfactory neurosphere-derived (ONS) cells, expressing GFAP (C) and O4 (D), or neuron-like 
cells, expressing β-tubulin III (E) and MAP2 (F).  Real Images Adapted from (53) 
 
 
On the other hand, there is always the possibility to differentiate the OE-MSCs into 
neuron-like cells by re-plating them in neurobasal medium supplemented with B27, nerve growth 
factor (NGF), glutamine and glutamate (53, 66, 88). These β-tubulin III and MAP2–expressing cells 
are potential candidates for cell therapy uses in brain diseases or trauma (53). 
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1.3.3. Stem/progenitor markers in the olfactory mucosa 
Nestin, an intermediate filament protein expressed in neural stem cells in the brain, was 
identified as a stemness marker in olfactory mucosa neurospheres as well as primary cultures of 
olfactory mucosa (62, 66). Stem cells from the lamina propria were also described to express NG2, 
often referred to as stem cell marker, such as nestin (76). 
However, prior to neurospheres formation, that indicates stemness per se, the isolation of 
olfactory stem tissue is a crucial step. In general, it was not clear in the description of the 
preparations of olfactory stem cells whether the LP or EPI were present or totally absent. 
Contamination of OE cultures with cells from the LP and vice versa could be occurring in such 
studies due to the difficulty in completely removing the LP during tissue dissection, since there 
were no differences observed in the biology of cells isolated from both LP and OE (71). On top of 
that, HBCs lack expression of standard neural progenitor markers such as Mash-1 (68, 89), 
detectable in GBCs (11). A group indicated ICAM-1 (CD54) as marker for HBC stem cells, since they 
were able to purify these cells by fluorescence-activated cell sorting (FACS) using antibodies to 
that protein (68). However, ICAM-1 labels other cell types in OM cultures, such as αSMA-positive 
(smooth muscle actin) smooth muscle cells, what makes it nonspecific (71). 
Another study described the purification of HBC and GBC with individual antibodies for 
each type of cells – BS-1 and GBC-2, respectively, but overlooked LP derived cells (69). 
After culturing embryonic rat OM tissue in conditions known to promote neural stem cells 
proliferation and formation of neurospheres, others identified two distinct populations of spheres 
and subsequently cytokeratins and Stro-1 as OE and LP specific markers, respectively (71). Such 
markers were confirmed to be expressed in a report on transplant-mediated repair properties of 
rat olfactory mucosal sphere-forming cells (82) and in a recent study about the anatomic 
distribution of the adult human nasal mesenchymal stem cells, Stro-1 was even used to identify 
LP-derived neurospheres (90). This may represents a way to hereafter improve the standard 
protocols for isolating nasal olfactory stem cells. 
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2. AIMS OF THE DISSERTATION 
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The possibility to investigate the molecular and cellular basis of neuropathologies using 
stem cells based models systems has been widely explored in the last few years. Recently, both 
epithelium and lamina propria-derived stem cells isolated from olfactory mucosa have attracted 
interest among the scientific community. The innovation of these model systems is the advantage 
of an easily accessible location, high proliferation rate, ability to proliferate in long-term cultures 
and tendency to differentiate into neuronal-like cells and neurosphere-derived cells (ONS cells). 
Nonetheless, the main reason for the upcoming interest in this specific cell type is their ability to 
demonstrate disease-related differences in gene expression, protein expression and cell function 
(i.e.: schizophrenia, Parkinson’s disease, and familial dysautonomia). 
 
Therefore, the main objectives of this dissertation were: 
 
1. Isolate and proliferate olfactory mucosa-derived stem cells; 
2. Induce olfactory neurospheres formation from both epithelium and lamina 
propria derived stem cells; 
3. Differentiate neurospheres into both neuron-like cells and olfactory neurosphere-
derived cells (ONS); 
4. Characterize both model systems: neuron-like cells and olfactory neurosphere-
derived cells; 
5. Differentiate neurosphere-derived cells by gradual serum deprivation. 
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3. MATERIALS AND METHODS 
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3.1. Isolation and proliferation of olfactory mucosa-derived stem cells 
The procedures used throughout the isolation and culture of olfactory mucosa-derived 
stem cells were based on a recent report by Girard and co-workers (53) and also based on 
previous work developed at our laboratory (91). 
 
3.1.1. Isolation of olfactory mucosa 
Olfactory mucosa was obtained from Wistar female rats (12-22 weeks old) handled 
according to the European Union directives (86/609/EEC). These rats were acquired from Instituto 
de Biologia Molecular e Celular (IBMC) and housed under controlled conditions (26˚C under a 12 
hour light/dark cycle) with water and food available ad libitum. 
Animals were sacrificed by rapid cervical stretching followed by decapitation. Skin was 
removed in order to remove the lower jaw with scissors and a rongeur, and to eliminate the facial 
muscles on both sides. The bone covering the nasal cavity was removed also with a rongeur, one 
side at a time, starting from the back incisors. Then, the olfactory turbinates were discarded to 
expose the olfactory mucosa. Lying on the septum, the olfactory mucosa biopsies were collected 
and transferred to 35 mm Petri dishes filled with serum-free culture medium (DMEM/HAM F12). 
 
3.1.2. Establishment of primary stem cell cultures 
Olfactory mucosa biopsies from both sides of the nasal septum were washed three times 
in DMEM/HAM F12 to remove the mucus and then incubated in a 35 mm Petri dished filled with 
1ml of dispase II solution (2,4 IU/ml), for 1 hour at 37˚C. Then, the lamina propria was carefully 
separated from the underlying olfactory epithelium, according to their appearance over a dark 
background. The striped orange/brown lamina propria was transferred to a new 35 mm culture 
dish with DMEM/HAM F12. The thinner and translucent epithelium was also placed in a 35 mm 
dish also filled with DMEM/HAM F12. 
After isolation, both tissues were cut into small pieces using 25 gauge needles and the 
culture medium with the floating fragments was transferred to two independent 15 ml tubes. The 
tubes were then centrifuged 3 minutes at 1000 rpm and the pellets re-suspended in 1 ml of 
collagenase IA solution (2,5 mg/ml). After dissociate the tissues using a sterile plastic pipette, the 
tubes were incubated for 10 min at 37˚C. To terminate the dissociation, the tubes were gently 
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rocked and 9 ml of Ca-free and Mg-free PBS (1x PBS) were added to each one. The tubes were 
then centrifuged at 1000 rpm for 5 minutes and the supernatants discarded. The cell pellets were 
re-suspended in 2 ml of DMEM/HAM F12 culture medium (supplemented with 10% fetal bovine 
serum [FBS] and 1% penicillin/streptomycin [Pen/Strep]) and plated in 35 mm cell culture dishes. 
All cultures were grown under standard conditions at 37˚C and 5% CO2 and for both tissue types 
the culture medium was totally renewed every 2 to 3 days. These primary cell cultures will grow 
until confluence been reached. 
 
3.1.3. Propagation of stem cells 
After the establishment of the primary stem cell cultures in 35 mm, they will be divided. 
The culture medium was aspirated and cells were washed 2 times with 1x PBS. The cells were 
then incubated with 750 µl of 0,05% trypsin-EDTA solution (Life Technologies) for 3 minutes at 
37˚C and after that time 2 ml of complete medium (DMEM/HAM F12 supplemented with 10% FBS 
and 1% Pen/Strep) were added to the culture dishes. The cells were then re-suspended and 
plated in a 60 mm plastic culture dish and further incubated at 37˚C and 5% CO2. 
When these plates become confluent they were further divided. The culture medium was 
removed and the cells were washed with 1x PBS. The cells were then incubated with 1 ml of 
0,05% trypsin-EDTA solution for 3 minutes at 37˚C and after that time 3 ml of complete medium 
were added to the culture dishes. The cells were then re-suspended and plated in a 100 mm 
culture dish. 
Once these stem cells reached confluence, they were further divided as previously 
mentioned using a 0,05% trypsin-EDTA solution. One single 100 mm plate will be split into 2 100 
mm plates. Whenever the cells reached the confluence state, this cells passage procedure was 
repeated. 
 
3.1.4. Cryopreservation of stem cells 
Epithelium and lamina propria-derived stem cells from confluent 100 mm culture dishes 
were washed twice with 1x PBS and dissociated with 2 ml trypsin-EDTA solution for 3 minutes at 
37˚C. After that period of time, 5 ml of complete medium were added to the culture dishes and 
the cells re-suspended and transferred to a 15 ml tube. After cells centrifugation for 5 minutes at 
1000 rpm, the cell pellet was re-suspended in 1 ml of FBS with 10% DMSO and transferred to a 
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cryopreservation vial. The vial was frozen at -80˚C overnight in a cryo cooler and then transferred 
into a nitrogen cryotank, correctly identified with the cell type, passage number and freezing 
date. 
 
3.2. Formation and growing of neurospheres 
The primary stem cells can be induced to form neurospheres. Briefly, the culture medium 
from confluent cultures of lamina propria and epithelium was aspirated and cells were washed 
with 1x PBS. The cells were then incubated with 2 ml of trypsin-EDTA solution for 3 minutes at 
37˚C. After that period of time, 2 ml of complete medium were added to culture dishes. Culture 
medium with the re-suspended stem cells was then transferred to 15 ml tubes that were 
centrifuged at 1000 rpm for 4 minutes. After the removal of the supernatants, the cell pellets 
were re-suspended in 4 ml of supplemented medium (DMEM/HAM F12 supplemented with 1% 
ITS-X [insulin, transferrin, selenium], 50 ng/ml EGF; 50 ng/ml FGF2 and 1% Pen/Strep) and plated 
on poly-D-lysine-coated 60 mm cell culture dishes. All cultures were maintained under standard 
conditions at 37˚C and 5% CO2. For both cell types (epithelium and lamina propria) a quarter of 
the culture medium was changed every 2 to 3 days. 
 
3.3. Formation and proliferation of ONS cells 
Culture medium with floating neurospheres was transferred to 15 ml tubes and the 2 ml 
of serum-free medium were added to the dishes to perform fluxes and refluxes with a 
micropipette, in order to release neurospheres that were still adherents. This suspension with 
neurospheres was to the 15 ml tubes previously used and the tubes were centrifuged at 1000 rpm 
for 4 minutes. After the removal of the supernatants, the cell pellets were re-suspended in 1 ml of 
trypsin-EDTA solution and incubated 1 minute at 37˚C. 
After that period of time, 2 ml of complete culture medium were added and then the 
tubes were centrifuged at 1000 rpm for 3 minutes. After the removal of the supernatants, the cell 
pellets were re-suspended in 2 ml of serum-containing culture medium and re-plated on poly-D-
lysine coated 35 mm cell culture dishes. Olfactory neurosphere-derived (ONS) cells were grown 
under standard conditions at 37˚C and 5% CO2. Whenever the cells reached the confluence state, 
the cells passage procedure described in section 3.1.3 was repeated. 
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To cryopreserve ONS cells, the protocol described in section 3.1.4 was repeated. 
 
3.4. Culture of ONS cells in defined medium 
As mentioned previously, the proliferation of ONS cells is achieved using complete 
medium. Here we adapt ONS to the absence of serum over 2 weeks through a gradual diminution 
of the serum percentage (10%, 5%, 2.5%, 1.25%, 0.625% to 0%). The serum percentage was 
reduced by half every 2 days. Since the cells would not survive in serum-free medium, they were 
placed in defined media, which consisted of DFN2 (DMEM/HAM F12 with 1% N2) or DFB27 
(DMEM/HAM F12 with 2% B27). 
In order to analyze the effects of serum reductions and defined media on cell 
morphology, coverslips with adherent cells were collected at several time points and cells were 
fixed using 4% paraformaldehyde as further detailed in section 3.6. 
 
3.5. Formation and proliferation of neuron-like cells 
Culture medium with floating neurospheres was transferred to 15 ml tubes and then 2 ml 
of serum-free culture medium were added to the dishes to perform fluxes and refluxes with a 
micropipette, in order to release neurospheres that were still adherents. This suspension with 
neurospheres was added to the 15 ml tubes previously used and the tubes were centrifuged at 
1000 rpm for 4 minutes. After the removal of the supernatants, the cell pellets were re-
suspended in 1 ml of trypsin-EDTA solution and incubated 1 minute at 37˚C. After that time, 2 ml 
of complete medium were added and then the tubes were centrifuged at 1000 rpm for 4 minutes. 
After the removal of the supernatants, the cell pellets were re-suspended in 2 ml of Neurobasal 
medium (Gibco), containing  1x B-27, 0,5 mM glutamine, 0,025 mM glutamate, 1% Pen/Strep, 50 
ng/ml NGF and phenol red; and then plated on poly-D-lysine-coated 35 mm culture dishes with an 
equally coated coverslip. All cultures were grown under standard conditions at 37˚C and 5% CO2 
and a quarter of the culture medium was changed every 2 to 3 days. 
These cells were maintained for 37 days and their morphologic evaluation was achieved 
by taking photos during such time. Morphometric analysis was performed on photomicrographs 
acquired from live cells using phase contrast illumination in an Olympus IX-81 motorized inverted 
microscope. Images of 20 fields per culture dish obtained at several time points (1 - 6, 9, 16, 23, 
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30 and 37 days) using AnalySIS (Olympus) software were analyzed and neurite length was 
measured using the image analyzer software ImageJ. 
 
3.6. Immunocytochemistry 
Cells grown on poly-D-lysine coated coverslips were fixed with a 4% paraformaldehyde 
solution. Briefly, after the aspiration of the culture medium and 3 washes with serum-free 
medium, a mixture of 0,5 ml of serum-free medium and 0,5 ml of 4% paraformaldehyde were 
added to the culture dish for 2 minutes. Then, the medium/paraformaldehyde solution was 
removed and 1 ml of 4% paraformaldehyde was added to the dish. After 25 minutes and 5 washes 
(10 minutes each) with 1x PBS, the cells were incubated with 0,2% Triton X-100 in 1x PBS for 10 
minutes, for permeabilization. After that period of time, cells were rinsed 5 times with 1x PBS and 
blocked for 1 hour with a solution of 3% BSA in 1x PBS. 
The cells were then incubated for 4 hours at room temperature with the primary antibody 
diluted in the blocking solution (Table 1). After this time, cells were washed 3 times with 1x PBS. 
The respective secondary antibody (diluted in the same blocking solution) was added and after 2 
hours at room temperature the dishes were rinsed 3 times with 1x PBS and the coverslips 
mounted in slides using mounting medium with DAPI (VECTASHIELD). These coverslips were 
further visualized and imaged using an epifluorescent Olympus IX-81 motorized inverted 
microscope. 
 
 
Table 1 – Antibodies used for immunocytochemistry. Dilutions used are indicated for both primary and secondary 
antibodies. 
Target protein Primary antibody Secondary antibody 
Nestin 
Monoclonal Mouse (MAB-353; 
Millipore) 
Dilution – 1:100 
Alexa Fluor 488 goat anti-
mouse IgG (LifeTechnologies) 
Dilution - 1:300 
β-tubulin III 
Monoclonal Mouse (Promega) 
Dilution – 1:5000 
Alexa Fluor 488 goat anti-
mouse IgG (LifeTechnologies) 
Dilution - 1:300 
 
Establishing model systems from olfactory mucosa stem cells 
 
32 
 
 
  
Establishing model systems from olfactory mucosa stem cells 
33 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. RESULTS 
 
  
Establishing model systems from olfactory mucosa stem cells 
 
34 
 
 
  
Establishing model systems from olfactory mucosa stem cells 
35 
 
The procedures used throughout the isolation and culture of olfactory mucosa-derived 
stem cells were based on a recent report by Girard and co-workers (53) and also based on 
previous work developed at our laboratory (91). 
After the isolation of olfactory mucosa-derived stem cells, we established cultures of both 
epithelium and lamina propria stem cells that were further used in several experiments (Figure 9). 
Firstly, after these epithelium and lamina propria stem cells were established, they were induced 
to form neurospheres by culturing them in an adequate medium supplemented with FGF and 
EGF. The resulting neurospheres were then plated into neurobasal medium containing NGF in 
order to being differentiated into neuron-like cells or plated in DMEM/F12 complete medium in 
order to being differentiated into olfactory neurospheres derived cells (ONS). The well-established 
ONS were then adapted to the absence of serum and cultured in either N2 or B27 supplemented 
medium to induce some phenotypic changes that are consistent with a neuronal like phenotype. 
All these procedures are summarized in Figure 9. 
Microphotographs were taken for morphologic characterization of all procedures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stem cell 
cultures  
Neurospheres 
ONS 
ONS 
differentiation 
Neuron-like 
cells 
Figure 9 – Outline of the experimental procedures. ONS – olfactory neurospheres derived cells. 
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4.1. Isolation and proliferation of olfactory mucosa-derived stem cells 
Olfactory mucosa was obtained from several Wistar female rats sacrificed by rapid 
cervical stretching followed by decapitation. After skin, lower jaw and facial muscles removal, the 
bone covering the nasal cavity was removed in order to discard the olfactory turbinates. This was 
a crucial step since the underlying olfactory mucosa tends to cling to the olfactory turbinates, 
what can result in biological material loss. Biopsies of olfactory mucosa were then carefully 
collected. 
After a first digestion with 2,4 IU/ml dispase II solution for 1h at 37˚C, epithelium and 
lamina propria were separated and isolated based on their appearance (color and thickness). The 
olfactory epithelium was thinner and looked white or translucent, while the lamina propria was 
darker, striped orange/brown. A further digestion with 2,5 mg/ml collagenase IA solution was 
performed and after tissue dissociation, epithelium and lamina propria cells were plated 
separately in 35 mm culture dishes filled with complete medium (DMEM/HAM F12, 10% FBS, 1% 
Pen/Strep). 
As described in literature (53), around day five after isolation, stem cells began to widely 
invade the culture dishes. However, as soon as day 2, some cells can be seen evading from the 
tissue fragments, in spite of numerous cells present in suspension and some tissue debris (Figure 
10). 
 
 
 
 
 
 
 
 
Epithelium Lamina Propria 
Figure 10 – Olfactory mucosa stem cells (epithelium and lamina propria) after isolation. Biopsies of olfactory mucosa 
were collected and the epithelium (A and B) was separated from the underlying lamina propria (C and D). Both types 
of cells were plated in 35 mm culture dishes filled with complete medium, and phase-contrast microphotographs 
were taken two days after platting. Scale bar = 100 µm 
A B C D 
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Both types of isolated and proliferated olfactory stem cells – epithelium (EPI) and lamina 
propria (LP) are considered primary cultures. Whenever these both cell types reached confluence, 
they were divided and maintained in cultures (according to the passage procedure described in 
3.1.3 and passage number (PN) and respective day in culture registered). These cells were kept in 
culture for long periods (several months), maintaining all the morphological characteristics and 
the stemness properties. In Figure 11 is represented an example of cells from one of the isolation 
procedures, kept in culture for 20 passages (PN 20, 4 months). 
 
 
Epithelium and lamina propria stem cells were described to have an elongated shape and 
proliferate as adherent monolayers. To evaluate the efficiency of our isolation and establishment 
procedures, we examined the morphology of both cultured cells (EPI and LP). Thus, microscopic 
examination of cultured cells was achieved during the proliferation phase and phase-contrast 
microphotographs were taken. Images of the primary cultures of both EPI and LP are presented in 
Figure 12, where we observe that these cultures are mainly composed by elongated adherent 
cells and there were no significant morphological differences between epithelium and lamina 
propria derived cells. 
 
 
 
Figure 11 - Passage number and respective days in culture for primary cultures of both EPI and LP. Stem cells from 
this isolation were kept in cultures for 240 days and almost 50 passages so far. Data shown only for the first 20 
passages. EPI – epithelium, LP – lamina propria 
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To confirm the stemness of the cultured cells, epithelium and lamina propria derived cells 
were immunolabeled with anti-Nestin monoclonal antibody. This labeling was complemented by 
nuclei labeling with DAPI. From the immunofluorescence images obtained, we could observe that 
our cultures expressed nestin, either in epithelium or lamina propria derived cultures (Figure 13). 
Being nestin a stemness marker, we can assume that we successfully isolated stem cells from both 
epithelium and lamina propria. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Epithelium Lamina Propria 
Figure 12 – Olfactory mucosa-derived stem cells morphology. Phase-contrast microphotographs taken from primary 
cultures isolated from epithelium (A and B) and lamina propria (C and D) cultured in DMEM/HAM F12, 10% FBS, 1% 
Pen/Strep. Scale bar = 200 µm 
A B C D 
Figure 13 – Nestin immunolocalization in epithelium (A and D) and lamina propria derived stem cells (G and J) 
isolated from olfactory mucosa. Cell nuclei were simultaneously stained with DAPI (B, E, H and K). The merge images 
are also presented (C, F, I and L). Scale bar = 100 µm 
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4.2. Cryopreservation of olfactory stem cells (Epithelium and Lamina 
Propria) 
In order to produce stocks of stem cells from both epithelium and lamina propria to use 
whenever necessary, both cell types were frozen using FBS with 10% DMSO. After a couple of 
days, they were unfrozen to evaluate possible effects of the freezing on cell morphology and 
viability. Three days later, coverslips of the unfrozen cells were collected and fixed to be analyzed 
by microscopy and the results are presented in Figure 14. 
 
 
 
 
 
 
From the photomicrographs taken (Figure 14), it can be assumed that the morphology of 
the cryopreserved stem cells was not affected by the freeze-thawing cycle. Olfactory stem cells 
kept their elongated shape, growing as adherent monolayer, exactly as before (Figure 12). 
Regarding the cellular viability, some dead cells can be observed in both epithelium and lamina 
propria, although lamina propria culture appears to be more confluent than epithelium. 
To confirm the stemness of the unfrozen cells, epithelium and lamina propria derived cells 
were immunolabeled with anti-Nestin monoclonal antibody. This labeling was complemented by 
nuclei labeling with DAPI. From the immunofluorescence images obtained, we could observe that 
our epithelium and lamina propria derived cultures stemness properties resisted the freeze-
thawing cycle (Figure 15). 
 
 
 
 
 
 
Figure 14 – Morphologic aspect of both cryopreserved epithelium (A and B) and lamina propria (C and D) stem cells. 
Cells were frozen using FBS with 10% DMSO and unfrozen to evaluate cell morphology. Scale bar= 200 µm 
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4.3. Induction of olfactory neurospheres formation and growing 
After the establishment of primary cultures for both epithelium and lamina propria, we 
proceed to the induction of neurospheres formation. For that purpose, we platted the olfactory 
stem cells onto 60 mm culture dishes previously coated with poly-D-lysine. The neurospheres 
induction was achieved using DMEM/HAM F12 medium supplemented with ITS-X (1%), EGF (50 
ng/ml) and FGF (50ng/ml). 
To carry further neurosphere formation procedures, we used cells from 70-75% confluent 
100 mm culture dishes (45.000-55.000 cells/cm2) and established several neurospheres culture 
dishes for both culture type (lamina propria and epithelium). For either culture type a quarter of 
the medium was changed every 2 days. 
Figure 15 - Nestin immunolocalization in cryopreserved epithelium (A and D) and lamina propria derived stem cells 
(G and J). Cell nuclei were simultaneously stained with DAPI (B, E, H and K). The merge images are also presented (C, F, 
I and L). Scale bar = 100 µm 
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As seen in Figure 16 (A, B, K and L), 24 hours after being plated in supplemented medium, 
olfactory cells from both culture types had already attached to the coated culture dishes and 
started to organize into clumps. These tendency resulted in cell aggregates that proliferate and 
give rise to neurospheres around day 3 (Figure 16, E, F, O and P), that continue to develop. 
Although some neurospheres appeared to float at day 4, olfactory neurospheres were collected at 
day 5 (Figure 16, I, J, S and T), since a higher number of neurospheres could be collected and used 
in further experiments. At this time point the majority of cells in the dishes were organized into 
floating neurospheres, which were spherical and optically dense with a well-defined contour, and 
the remaining neurospheres attached to the dish surface were easily collected through gentle 
refluxes of the medium in the culture dish. No differences were observed between lamina propria 
and epithelium derived cultures and the diameter of the neurospheres were very similar among 
them (100-150 µm). 
 
 
 
 
Epithelium Lamina Propria 
Day 1 
Day 2 
Day 3 
Day 4 
Day 5 
A B 
C D 
E F 
G H 
I J 
K L 
M N 
O P 
Q R 
S T 
Figure 16 - Induction of olfactory neurospheres formation from epithelium and lamina propria. Cells were plated on 
60 mm culture dishes coated with poly-D-lysine. Phase-contrast photomicrographs of epithelium and lamina propria 
derived neurospheres were taken at day 1 (A, B, K and L), day 2 (C, D, M and N), day 3 (E, F, O and P), day 4 (G, H, Q and 
R) and day 5 (I, J, S and T). Scale bar = 100 µm 
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At day 3, coverslips with adherent neurospheres were also collected and cells fixed to 
perform immunocytochemistry analysis. Neurospheres were then immunolabeled with anti-
Nestin antibody (stemness marker) to verify that stem cells are indeed the ones forming 
neurospheres. In Figure 17, we can clearly observe the tendency of cells to orient themselves into 
flat clumps (Figure 17, A, B, C, M, N and O), where rapid proliferation occurs (Figure 17, G, H, I, P, 
Q and R) in order to form free-floating neurospheres. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17 – Nestin immunolocalization in neurospheres from epithelium (A, D and G) and lamina propria (J, M and 
P). Cell nuclei were simultaneously stained with DAPI (B, E, H, K, N and Q), at day 3. Scale bar = 100 µm 
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4.4. Neurospheres differentiation into neuron-like cells 
The floating neurospheres were collected and further differentiated into neuron-like cells 
(NLC) using neurobasal medium containing 1x B-27, 0,5 mM glutamine, 0,025 mM glutamate, 1% 
Pen/Strep and 50 ng/ml NGF. Briefly, after a slight disaggregation trough trypsin action, 
neurospheres were platted in Neurobasal medium and kept in culture for 37 days. Ten 35 mm 
culture dishes were established for each culture type (epithelium and lamina-propria). Phase-
contrast photomicrographs were taken every day from day 1 to 6 and then at day 9, 12, 16, 23, 30 
and 37. For a morphometric analysis of these neuron-like cells, a total of 4.800 images of all 
conditions were analyzed in terms of cell number and neurite length using ImageJ software. 
As seen in Figure 18,  24 hours after being plated, the majority of neurospheres were 
imperceptible and the cells were well distributed all over the culture dishes. Some processes, 
similar to neurites, soon arise from the cell bodies (Figure 18). Cells resemble neural cells, being 
hereafter named neuron-like cells.  
After analyzing Figure 18 it is evident that there was an increase in neurite length until 
Day 6 (Figure 18, Figure 20, Figure 21), although the number of neurites seems to decrease. After 
Day 6, though such processes are still present, their lengths decrease until Day 37 (Figure 19), 
when they reach a dimension similar to Day 1.  
In terms of cell number (Figure 20, Figure 21), although the mean calculated for the 
samples appears to decrease, the average deviation for those calculations ends up showing that 
cell number did not oscillated very much. 
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Figure 18 - Neurospheres differentiation into neuron-like cells from day 1 until day 6. Trypsin-disaggregated 
neurospheres were plated with neurobasal medium on 35 mm culture dishes coated with poly-D-lysine. Phase-contrast 
photomicrographs of epithelium and lamina propria derived neuron-like cells were taken at day 1 (A, B, M and N), day 2 
(C, D, O and P), day 3 (E, F, Q, R), day 4 (G, H, S and T), day 5 (I, J, U and V) and day 6 (K, L, W and X). Scale bar = 100 µm 
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Figure 19 - Neurospheres differentiation into neuron-like cells from day 9 until day 37. Trypsin-disaggregated 
neurospheres were plated with neurobasal medium on 35 mm culture dishes coated with poly-D-lysine. Phase-contrast 
photomicrographs of epithelium and lamina propria derived neuron-like cells were taken at day 9 (A, B, M and N), day 12 
(C, D, O and P), day 16 (E, F, Q and R), day 23 (G, H, S and T), day 30 (I, J, U and V) and day 37 (K, L, W and X). Scale bar = 
100 µm 
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The morphometric quantitative analysis of all images taken during the time course of 
differentiation of neurospheres into neuron-like cells is presented in Figure 20 (epithelium) and 
Figure 21 (lamina propria). In summary, we measured the number and length of neuritis and we 
counted the total number of the cells. For this analysis, we used the ImageJ software. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20 - Epithelium neurospheres derived neuron-like cells morphometric analysis. Images from 10 independent 
experiments were analyzed in terms of neurite length and cell number. Error bars represent the quotient of standard 
deviation and square rout of the number of samples (in neurite length series) and average deviation (in cell number 
series). 
Figure 21 - Lamina Propria neurospheres derived neuron-like cells morphometric analysis. Images from 10 
independent experiments were analyzed in terms of neurite length and cell number. Error bars represent the quotient 
of standard deviation and square rout of the number of samples (in neurite length series) and average deviation (in cell 
number series). 
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At day 37, cells were also fixed and further analyzed by immunocytochemistry. Cells were 
immunolabeled with anti-β-tubulin III antibody (neuronal marker) and nuclei were labeled with 
DAPI. From the immunofluorescence images obtained (Figure 22) we can observe that our so 
called neuron-like cells are indeed expressing β-tubulin III, a microtubule element expressed in 
neurons. No significant differences were observed between epithelium and lamina propria 
neurosphere-derived neuron-like cells. 
 
  
Figure 22 - β-tubulin III immunolocalization in neuron-like cells derived from epithelium (A, D and G) and lamina 
propria (J, M and P) neurospheres. Cell nuclei were simultaneously stained with DAPI (B, E, H, K, N and Q), at day 37. 
The merge images are also presented. Scale bar = 20 µm 
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4.5. Neurospheres differentiation into ONS cells 
Additionally, neurospheres of both EPI and LP could also be differentiated into olfactory 
neurosphere-derived cells (ONS) using DMEM/HAM F12, 10% FBS, 1% Pen/Strep (complete 
medium). Briefly, after a slight disaggregation trough trypsin action, neurospheres were platted in 
complete medium on 35 mm culture dishes coated with poly-D-lysine, re-attached to the culture 
dishes and start to differentiate. Total medium was renewed every 2 days. 
A few days after being plated, both lamina propria and epithelium derived neurospheres 
were flattened and cells were proliferating from the neurospheres periphery. Single cells were 
also differentiating. At day 7 (Figure 23, A, B, E and F) cells were rapidly proliferating as an 
adherent monolayer and one week later (Figure 23, C, D, G and H) either epithelium and lamina 
propria derived ONS were confluent and could be passed into 60 mm culture dishes.  
 
 
 
Both culture types were expanded for further experiments and at passage number 10 
new morphological analysis was performed, what confirmed the elongated and adherent 
monolayer growing features of these cells. No morphological differences were detected between 
epithelium and lamina propria derived ONS cells once again (Figure 24). 
 
 
 
 
Figure 23 – Olfactory neurosphere-derived cells (ONS). Trypsin disaggregated neurospheres were plated on 35 mm 
culture dishes filled with complete medium. Phase-contrast photomicrographs taken from ONS of epithelium at day 7 
(A and B) and 14 (C and D), and from lamina propria also at day 7 (E and F) and day 14 (G and H). Scale bar = 100 µm 
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ONS cells from both culture types were expanded in culture for 14 passages so far, and a 
similar behavior (growing and days in culture between passages) was observed (Figure 25). Stocks 
of these cells were also banked down in aliquots after harvest by storage in liquid nitrogen with 
FBS and 10% DMSO. 
 
 
 
 
 
 
 
 
 
 
 
 
In order to verify if ONS cells express nestin as previously reported (45), epithelium and 
lamina propria derived ONS cells were immunolabeled with anti-Nestin monoclonal antibody. This 
labeling was complemented by nuclei labeling with DAPI. From the immunofluorescence images 
obtained, we could observe that both epithelium (Figure 26, A and D) and lamina propria derived 
ONS cells (Figure 26, G and J) expressed the stemness marker nestin, although some cells present 
a low intensity of nestin immunolabeling. 
Figure 24 – Olfactory neurosphere-derived cells (ONS) morphology. ONS derived from both epithelium and lamina 
propria were kept in culture with complete medium and phase-contrast photomicrographs were taken at passage 
number 10. Scale bar = 200 µm  
Figure 25 - Passage number and respective days in culture for ONS cells derived from EPI and LP. ONS cells were kept 
in cultures 14 passages so far. ONS – olfactory neurospheres derived cells, EPI – epithelium, LP – lamina propria 
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4.6. ONS cells differentiation 
As previously reported (92), ONS cells could be differentiated by gradual serum 
deprivation and at the end they possess a phenotype very similar to neuronal cells. Therefore, in 
order to differentiate ONS cells into neuronal-like cells, they were adapted to the absence of 
serum over 2 weeks through a gradual serum deprivation (10%, 5%, 2,5%, 1,25%, 0,625% to 0%). 
The serum percentage was reduced by half every 2 days, until they could be placed in defined 
media, which consisted of DFN2 (DMEM/HAM F12 with 1% N2) or DFB27 (DMEM/HAM F12 with 
2% B27). 
Serum reduction was started in 70-75% confluent culture dishes from both epithelium 
and lamina propria derived ONS, since it was predictable that cells would not proliferate as much 
as usual when the serum was reduced. 
Figure 26 - Nestin immunolocalization in epithelium (A and D) and lamina propria derived ONS cells (G and J). Cell 
nuclei were simultaneously stained with DAPI (B, E, H and K). The merge images are also presented (C, F, I and L). Scale 
bar = 100 µm 
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In Figure 27, we have the results regarding to gradual serum deprivation. We can observe 
that ONS cells kept their elongated shape and proliferate even in less serum that usual. After the 
second serum reduction, when the cells were grown with 2,5% of serum, dishes become 
confluent and were therefore divided. 
 
 
 
Figure 27 – ONS cells differentiation by serum deprivation. ONS cells derived from both epithelium (A-L) and lamina 
propria (M-X) were adapted to the absence of serum by gradual reductions in serum percentage (10%, 5%, 2,5%, 1,5%, 
0,625%, 0%). Scale bar = 200 µm 
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For each cell type (epithelium and lamina propria ONS cells) two culture dishes were 
established. Two days after ONS cells were growing without any serum (0% serum), two new 
culture mediums were tested. One plate of each cell type was filled with DMEM/HAM F12, 1% N2 
and the other with DMEM/HAM F12, 2% B27. 
After a few days, cells begin to present a phenotype more similar to neuronal cells using 
both culture mediums (Figure 28, Figure 29, Figure 30 and Figure 31). They became confluent 4 
days after being plated and each of the plates were divided 1:2. However, after that, many cells 
failed to re-attach the culture dish, especially in the cultures with B27 supplemented-DMEM/HAM 
F12 medium (Figure 30). Meanwhile, the remaining attached cells not proliferated as expected, 
and started to die in culture, being discarded during the culture medium renewing procedure. 
These events were more notorious in lamina propria olfactory neurosphere-derived culture 
dishes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28 – Olfactory neurosphere-derived cells cultured in DMEM/HAM F12 with N2. Epithelium (A, B, C and D) and 
lamina propria (E, F, G and H) ONS were cultured in DMEM/HAM F12, 1% N2. Scale bar = 200 µm 
Figure 29 – Detail of olfactory neurosphere-derived cells cultured in DMEM/HAM F12 with N2. Epithelium (A and B) 
and lamina propria (C and D) ONS were cultured in DMEM/HAM F12, 1% N2. Scale bar = 100 µm 
A B C D 
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Figure 30 - Olfactory neurosphere-derived cells cultured in DMEM/HAM F12 with B27. Epithelium (A, B, C and D) and 
lamina propria (E and F) ONS were cultured in DMEM/HAM F12, 2% B27. Scale bar = 200 µm 
Figure 31 - Detail of olfactory neurosphere-derived cells from epithelium cultured in DMEM/HAM F12 with B27. 
Epithelium (A and B) ONS were cultured in DMEM/HAM F12, 1% N2. Scale bar = 100 µm 
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5. DISCUSSION 
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Neurogenesis continues throughout adult human life due to discrete pools of neural stem 
cells in the adult brain. Multipotent neural progenitors could present a valuable source of 
information on neurogenesis process under normal and abnormal conditions, including neuronal 
migration, maturation and synapse formation, without ethical and legal problems like those 
associated with ES cells (22). However, their intracranial localization requires a highly invasive 
surgery for their collection. The olfactory mucosa represents the only source of neuronal cells of 
the body easily accessible, what explains a renewed interest among researchers. 
Neurodegenerative diseases such as schizophrenia, Alzheimer and Parkinson, can be studied or 
even detected through olfactory mucosa cells, that can be easily and non-harmfully collected in 
adult humans under local anesthesia (54). 
Neurogenesis within the olfactory mucosa occurs in stem cell niches in both the olfactory 
epithelium and the olfactory lamina propria (62). In the epithelium, two populations of stem cells 
contribute to the neurogenic process throughout life – the horizontal basal cells (HBCs) and the 
globose basal cells (GBCs). Adult HBCs rarely divide, but can replenish GBCs progenitors, and they 
can generate neurons and cells outside the neural lineage. Lamina propria-derived stem cells 
were described to have an high proliferation rate and be easily differentiated into neural and non-
neural cell types (71). 
After being characterized as olfactory ecto-mesenchymal stem cells (OE-MSC) (62), lamina 
propria-derived stem cells have been proposed as candidates to autologous transplant-mediated 
repair of the CNS after injury (78) and model systems to study neuropathologies  such as 
schizophrenia and familial dysautonomia (45, 51). 
In the work here presented we intend to isolate and proliferate olfactory mucosa-derived 
stem cells. In essence, we successfully isolated and proliferated both epithelium and lamina 
propria-derived stem cells. The accomplishment of this objective was possible due to a recent 
report by Girard (53) and a previous work performed in our laboratory (91). During this isolation 
procedure the separation between epithelium and lamina propria is the most difficult step, since 
the visual barrier between these two tissues is almost imperceptible. Therefore we could have 
lamina propria biopsies contaminated with epithelium cells and vice versa. However, we strongly 
believe that our epithelium and lamina-propria cultures are not pure but are highly enriched in 
each cell type. A recent study suggested an option form the improvement of this isolation step 
using Stro-1 and cytokeratins as tissue-specific cell markers (71). While cytokeratins are 
specifically expressed by the epithelium cells, Stro-1 is only expressed in the lamina propria cells. 
Additionally, cytokeratins are surface protein, which may aid separation. Other report (76) 
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described the use of a commercial kit to positively select OE-MSCs, that could also be adapted to 
our procedure workflow. 
After isolation, primary cultures of both olfactory mucosa were efficaciously established 
and proliferated as adherent monolayers of elongated, spindle-shaped cells according to 
expected. No morphological differences were observed between epithelium and lamina propria 
derived cultures (Figure 12). Additional nestin immunolabeling of cells from both types of primary 
cultures (Figure 13) confirmed that we successfully isolated and proliferated olfactory stem cells 
from the olfactory mucosa biopsies. Thus, we were able to proceed to further experiments using 
the primary monolayer stem cell cultures isolated. 
These primary stem cell cultures soon revealed to be very sensitive cultures and it became 
clear that the ability to have frozen stocks from both epithelium and lamina propria derived stem 
cells would be an enormous advantage for further usage of these cells in experimental 
procedures. Therefore, we tested the effects of a freeze-thawing cycle in the normal morphology 
and growing features of both stem cells cultures. Both epithelium and lamina propria cultures 
respond positively to freeze-thawing cycle, since they maintain their elongated, spindle-shaped 
morphology and still growing as adherent monolayers (Figure 14, Figure 15). Therefore, we 
conclude that they kept their normal growing properties, morphology and steaminess after a 
freeze-thawing cycle. This was a great advance for the use of these models system for the study of 
neuropathologies since we can skip the isolation step that is not always an easy step. Thus, at this 
moment, we have several aliquots of stem cells frozen, that can be unfrozen whenever necessary 
to carry with additional experiments. 
Since we efficiently proliferated epithelium and lamina propria stem cells we tested their 
ability to form neurospheres using a specific culture medium. This represents a very important 
step for the characterization of stem cells since only stem cells have this ability and therefore we 
efficiently isolate the stem/neurospheres-forming cells from those unwanted non-stem cells. 
Moreover, in complete medium (DMEM/HAM F12, 10% FBS, 1% Pen/Strep), ensheathing glial 
cells, fibroblasts, and stromal (sustentacular) eventually established in primary cultures from the 
isolated stem cells die via apoptosis within 3 weeks of culture (27). Therefore, neurospheres assay 
are crucial assays for the isolation of stem/neurosphere-forming cells from those unwanted non-
stem cells. The crucial step for induction of neurospheres formation is the initial cell density. 
Although it has been reported by Girard and co-workers that the ideal initial cell density 
for neurospheres formation is 16.000 cells/cm2 (53), other authors suggested an higher cell 
density: 50.000 cells/cm2 (58). Previous work of our own laboratory (91) demonstrated that this 
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higher value is the most favorable plating density to the formation of neurospheres. In our hands, 
the initial cell density for neurospheres induction was 45.000-55.000 cells/cm2. Once overpassed 
this initial cell density problem we efficiently induce the neurospheres formation from both 
epithelium and lamina propria established primary cultures (Figure 16).  
The analysis of the phase contrast microphotographs taken on both cultures during the 
neurospheres forming assay demonstrate the tendency of stem cells to organize into clumps 
when plated in FGF2, EGF and ITS-X supplemented culture medium (Figure 16). These results were 
of paramount importance since we not only confirm once again that we efficiently isolate and 
proliferate stem cells from both epithelium and lamina propria, but also that we are able to 
separate those stem cells from the contaminant non-stem cells. Therefore 1-2 days after plating 
the cells, they start to aggregate and these aggregates generate neurospheres that will be 
collected to further experiments after 5 days. Characterization of the neurosphere-forming cells 
was also performed in preparations of day 3-fixed neurospheres. This time point was chosen to 
avoid the inexistence of fixed cells, once neurospheres start to detach from the culture dishes at 
day 4. The immunolabeling with anti-Nestin antibody (Figure 17) revealed a high level of nestin in 
the neurospheres, which confirms that in fact those are indeed the stem cells. As expected we 
could induce the formation of neurospheres using both epithelium and lamina propria primary 
cells. The results so far indicate that we efficiently isolate, proliferate and separate the olfactory 
mucosa stem cells and therefore we are able to differentiate those into neuron-like cells and 
neurosphere-derived cells, that could be very relevant model systems for the study of 
neuropathologies. 
To assess neurospheres ability to differentiate into neuron-like cells (NLCs) and olfactory 
neurosphere-derived cells (ONS), neurospheres where collected at day 5, dissociated and re-
plated in the appropriate mediums. It is worth mentioning that the dissociation through trypsin 
action is a crucial step to proceed to differentiation procedures (91), although it was not 
mentioned in the work of Girard and co-workers (53).  
Our original protocol for NLC differentiation (91) that was similar to that proposed by 
Girard and Co-workers (53) did not include NGF in the differentiation culture medium and failed 
to differentiate neurospheres into neuron-like cells. According to that protocol, neuron-like cells 
should appear 2 to 3 weeks after the neurospheres being plated in differentiation medium. 
However, a previous work reported that few cells resisted for that long in such culture medium 
and the ones that survive long enough to differentiate died soon after week 3 (91). Thus, based 
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on other studies (27, 66), we decided to add NGF to the differentiation culture medium to provide 
an additional stimulus to the differentiating cells. 
After being re-plated in neurobasal medium containing 1x B-27, 0,5 mM glutamine, 0,025 
mM glutamate, 1% Pen/Strep, 50 ng/ml NGF and phenol red, dissociated neurospheres re-
attached to the new dish surface and processes that resemble neurite soon arise from the cell 
bodies and persisted during 37 days in culture (Figure 18, Figure 19). In fact, our morphometric 
analysis indicate that there was a significant increase in neurite length until day 6, although after 
that day there was some retraction in that measure. These results clearly confirm that 6 days 
after neurospheres differentiation we have neuron-like cells (Figure 18). These results were also 
confirmed by the immunolabelling of neuron-like cells with anti β-tubulin III antibody that is a 
neuronal lineage marker (Figure 22). The high expression levels of this protein indicate that we 
were well succeeded in obtaining neuron-like cells. These results should however be confirmed 
using additional protein markers of differentiation like synaptophysin and SNAP-25. 
When dissociated neurospheres were re-plated in complete culture medium, they easily 
attached to the new dish surface and olfactory neurosphere-derived cells (ONS) rapidly 
proliferated as an adherent monolayer (Figure 23). The immunolabelling of those cells with anti 
nestin antibody have indicated that some ONS cells still express nestin (Figure 26) as their 
neurospheres ancestors, but in apparently lower levels (less intense staining), as previously 
reported (45). We established ONS cell lines from both epithelium and lamina propria olfactory 
neurospheres. Therefore, we established an additional model system valuable for future 
experiments. Additionally, we have carried out some experiments were we differentiated ONS 
cells by serum deprivation. During the gradual serum deprivation ONS cells maintain their 
elongated shape, and after serum removal these cells were cultured in two different culture 
mediums: DMEM/F12 supplemented with B27 and DMEM/F12 with N2. Our results indicate that 
the medium with N2 is more adequate for the maintenance of the differentiated ONS cells, with a 
neuron-like phenotype (Figure 28, Figure 29, Figure 30 and Figure 31). However, additional 
experiments must me carried in order to optimize this procedure, in order to produce an 
additional model system based on differentiated ONS cells. 
From the results presented we might conclude that we efficiently isolate and proliferate 
rat olfactory mucosa stem cells from both epithelium and lamina propria that are easily 
differentiated into neurospheres and therefore separated from non-stem cells. The neurospheres 
were further differentiated into two valuable models systems that are neuron-like cells and 
olfactory neurosphere-derived cells. These two model systems were well characterized. 
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In conclusion, our results strength the hypothesis of using stem cells based model systems 
to study the cellular and molecular mechanisms underlying several neuropathologies, including 
Alzheimer’s disease. 
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I. Olfactory Stem Cells Isolation and Culture 
a) Equipment 
Centrifuge 5810 R (Eppendorf) 
 
b) Solutions 
Serum-free medium [DMEM/HAM F12 (1:1)] 
For one liter of medium, 
o DMEM (Sigma-Adrich)  6,7g 
Sodium Bicarbonate  1,85g 
o F12 (Life Technologies)  5,315 g 
Sodium Bicarbonate  0,588 g 
Adjust the pH of each solution to 7.3, mix both solutions and adjust the volume to 
1L with deionised H2O. Filter through a 0.2 μm filter to become sterile. 
 
Dispase II solution (2,4 IU/ml) 
For 1 ml of solution, mix 340 µl of dispase (10 mg/ml, Sigma-Aldrich) with 660 µl 
of serum-free medium. 
 
Collagenase IA reconstitution buffer 
o Tricine buffer  0,90 g (50 mM) 
o NaCl   2,34 g (400 mM) 
o CaCl2   0,15 g (10 mM) 
Adjust the pH to 7.4 and the volume to 100 ml with deionized H2O. Filter the 
solution through a 0,2 µm filter and store at 4˚C. 
 
Collagenase IA solution (2,5 mg/ml) 
 For 1 ml of solution, mix 250 µl of collagenase (10 mg/ml, Sigma-Aldrich) with 750 
µl of serum-free medium. 
 
PBS (1x) 
For a final volume of 500 ml, dissolve one pack of BupH Modified Dulbecco’s 
Phosphate Buffered Saline Pack (Pierce) in deionized H2O. Final composition: 
o 8 mM Sodium Phosphate 
Establishing model systems from olfactory mucosa stem cells 
 
76 
 
o 2 mM Potassium Phosphate 
o 140 mM Sodium Chloride 
o 10mM Potassium Chloride 
Sterilize by filtering through a 0,2 µm filter and store at 4˚C. 
 
Complete medium 
 For one liter of DMEM/HAM F12 (1:1), 10% FBS and 1% Pen/Strep, 
o DMEM     6,7g 
 Sodium Bicarbonate   1,85g 
 Pen/Strep (Life Technologies)  5 ml 
o F12     5,315 g 
 Sodium Bicarbonate   0,588 g 
Pen/Strep    5 ml 
Adjust the pH of each solution to 7.3, mix both solutions and adjust the volume to 
1L with deionised H2O. Add 100 ml of FBS (Invitrogen) and filter through a 0.2 μm filter to 
become sterile. 
 
Poly-D-lysine stock (10 mg/ml) 
 To a final volume of 10 ml, dissolve in deionized H2O 
o Poly-D-lysine (Sigma-Aldrich)  100 mg 
 
Borate Buffer stock 
o Boric Acid (Sigma-Aldrich)  9,28 g 
Adjust the pH to 8.2 and the final volume to 1L with deionized H2O. Sterilize by 
filtering through a 0,2 µm filter and store at 4ºC. 
 
Poly-D-lysine solution 
o Poly-D-lysine (10 mg/ml)  1 ml 
o Borate buffer    99 ml 
 
Supplemented medium (neurospheres) 
For approximately 100 ml of DMEM/HAM F12 (1:1), 1% ITS-X, 50ng/ml EGF, 
50ng/ml FGF2 and 1% Pen/Strep, 
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o Serum-free medium (DMEM/HAM F12)  100 ml 
o ITS-X (Invitrogen)    1 ml 
o EGF (100 µg/ml, Cell Signaling)   50 µl 
o FGF2 (50 µg/ml, Invitrogen)   100 µl 
o Pen/Strep     1 ml 
Filter through a 0.2 μm filter to ensure sterility. 
 
Neurobasal medium 
For 100 ml of neurobasal medium supplemented with 1x B-27, 0,5 mM glutamine, 
0,025 mM glutamate, 1% Pen/Strep, Phenol Red and 50 ng/ml NGF, 
o B27 (50x, Invitrogen)     2 ml 
o Glutamine (200 mM)     250 µl 
o Glutamate (10 mM)     250 µl 
o Pen/Strep      1 ml 
o Phenol Red (Sigma-Aldrich)    200 µl 
o NGF (100 µg/ml)     100 µl 
o Neurobasal medium (1x, Life Technologies)  96,2 ml 
Mix the components of the medium inside a laminar flow chamber to ensure 
sterility. 
 
DFN2 medium 
For approximately 100 ml of DMEM/HAM F12 medium supplemented with 1% N2 
and 1% Pen/Strep, 
o N2 (100x, Invitrogen)     1 ml 
o Pen/Strep      1 ml 
o Serum-free medium (DMEM/HAM F12)   100 ml 
Mix the components of the medium inside a laminar flow chamber to ensure 
sterility. 
 
DFB27 medium 
For approximately 100 ml of DMEM/HAM F12 medium supplemented with 2% 
B27 and 1% Pen/Strep, 
o B27 (50x, Invitrogen)     4 ml 
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o Pen/Strep      1 ml 
o Serum-free medium (DMEM/HAM F12)   100 ml 
Mix the components of the medium inside a laminar flow chamber to ensure 
sterility. 
 
II. Immunocytochemistry 
a) Equipment 
Olympus IX-81 motorized inverted microscope (equipped with LCPlanFI 20x/0.40 
objective lens) 
 
b) Solutions 
4% Paraformaldehyde 
o PBS (1x)   100 ml 
o Paraformaldehyde  4 g 
Filter with a 0,2 µm filter. 
 
0,2% Triton X-100 
o PBS (1x)   100 ml 
o Triton X-100   200 µl 
 
3% BSA (in PBS) 
o PBS (1x)   100 ml 
o Triton    3 g 
 
 
 
 
 
 
 
 
 
